持股变动声明
CervoMed(CRVO)02-29 06:15
$CervoMed(CRVO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-24-005918 Size: 10 KB 网页链接
简介：CervoMed Inc.于2015年6月18日在特拉华州注册成立。该公司是一家临床阶段的生物技术公司，致力于通过提高目前标准治疗（包括放射治疗和化疗）的有效性延长癌症患者的预期寿命。
| 今开：24.44 | 昨收：24.99 |
| 最高：25.5 | 最低：23.82 |
| 涨停价： | 跌停价： |
| 总市值：146980810 |
CervoMed(CRVO)02-29 06:15
$CervoMed(CRVO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-24-005918 Size: 10 KB 网页链接
CervoMed(CRVO)04-23 20:05
$CervoMed(CRVO)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001437749-24-012761 Act: 34 Size: 163 KB 网页链接
CervoMed(CRVO)02-29 05:25
$CervoMed(CRVO)$ 8-K Current report, items 1.01, 3.03, 8.01, and 9.01 Accession Number: 0001437749-24-005900 Act: 34 Size: 194 KB 网页链接
CervoMed(CRVO)03-07 05:15
$CervoMed(CRVO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-24-060715 Act: 34 Size: 87 KB 网页链接
CervoMed(CRVO)02-14 22:25
$CervoMed(CRVO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-24-035273 Act: 34 Size: 86 KB 网页链接
CervoMed(CRVO)02-10 05:35
$CervoMed(CRVO)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001437749-24-003646 Size: 15 KB 网页链接
CervoMed(CRVO)02-29 06:35
$CervoMed(CRVO)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001437749-24-005919 Act: 34 Size: 51 KB 网页链接
CervoMed(CRVO)04-06 04:15
$CervoMed(CRVO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001437749-24-011212 Act: 34 Size: 202 KB 网页链接
CervoMed(CRVO)02-08 05:15
$CervoMed(CRVO)$ 8-K Current report, items 5.02, 8.01, and 9.01 Accession Number: 0001437749-24-003357 Act: 34 Size: 219 KB 网页链接
CervoMed(CRVO)02-10 06:05
$CervoMed(CRVO)$ SC 13D General statement of acquisition of beneficial ownership Accession Number: 0001437749-24-003657 Act: 34 Size: 55 KB 网页链接
美股滚雪球2023-08-18 10:19
$Diffusion制药(DFFN)$ 和EIP制药(EIP Pharma)合并以及反向股票分割之后，新设立的$CervoMed(CRVO)$ 股票在交易的第一天飙升。
周二晚些时候，Diffusion宣布股东批准了合并。该公司还计划在上市前进行1比1.5的反向拆股，以符合纳斯达克的上市要求。合并后公司的股票原定于8月17日开始交易。
$CervoMed(CRVO)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001437749-24-012761 Act: 34 Size: 163 KB 网页链接
$CervoMed(CRVO)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-046428 Act: 34 Size: 89 KB 网页链接
$CervoMed(CRVO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001437749-24-011212 Act: 34 Size: 202 KB 网页链接
$CervoMed(CRVO)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001437749-24-010998 Act: 34 Size: 162 KB 网页链接
$CervoMed(CRVO)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001437749-24-010064 Act: 34 Size: 8 MB 网页链接
$CervoMed(CRVO)$ 8-K Current report, items 1.01, 3.02, 7.01, and 9.01 Accession Number: 0001437749-24-009697 Act: 34 Size: 1 MB 网页链接
$CervoMed(CRVO)$ 8-K Current report, items 5.08 and 9.01 Accession Number: 0001437749-24-008315 Act: 34 Size: 162 KB 网页链接
$CervoMed(CRVO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-24-060715 Act: 34 Size: 87 KB 网页链接
$CervoMed(CRVO)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001437749-24-006546 Act: 34 Size: 207 KB 网页链接
$CervoMed(CRVO)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001437749-24-005919 Act: 34 Size: 51 KB 网页链接